Literature DB >> 8109458

[Ca(2+)-ATPase activity in the hypocalcemic cataract].

H Takahashi1.   

Abstract

We used an animal model of hypocalcemic cataract to investigate the changes of the cation levels and the Ca2+ pump (Ca(2+)-ATPase) function in the lens. Wistar rats (4 weeks old) were fed with a low calcium and no vitamin D3 diet. After 4 weeks on this diet, anterior subcapsular cataract was recognized, when calcium concentration in the aqueous humor and serum had significantly decreased. Calcium content in the lens decreased and sodium content increased. Ca(2+)-ATPase activity detected by [gamma-32P] ATP assay did not show significant change. We concluded that cataract during the early stage of hypocalcemia is caused by membrane damage with low calcium level in the aqueous humor and sodium content increase in the lens. We also studied the ultracytochemical localization of Ca(2+)-ATPase activity and found it in the plasma membrane of the lens epithelium and cortex and also in the epithelium organelles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8109458

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  4 in total

1.  Vitamin D deficiency and posterior subcapsular cataract.

Authors:  Craig J Brown; Faical Akaichi
Journal:  Clin Ophthalmol       Date:  2015-06-16

2.  Bilateral hypocalcaemic cataracts due to idiopathic parathyroid insufficiency: A case report.

Authors:  Yan Li
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

3.  Quantitative investigation of the effect of surgically induced hypoparathyroidism on cataract development.

Authors:  Ali Mert Koçer; Mehmet Ali Şekeroğlu; Çağatay Emir Önder; Seda Çevik; Furkan Emre Söğüt; Şerife Mehlika Kuşkonmaz; Sibel Doğuizi
Journal:  J Bone Miner Metab       Date:  2021-07-27       Impact factor: 2.626

4.  Bilateral hypocalcemic cataract after total thyroidectomy in a young woman: case report.

Authors:  Kumale Tolesa Daba; Dagmawit Kifle Weldemichael; Gersam Abera Mulugeta
Journal:  BMC Ophthalmol       Date:  2019-11-21       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.